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the OXTR SNPs did not moderate these associations nor 
had main effects on outcomes.
Conclusions The three OXTR gene SNPs did not interact 
with childhood maltreatment in predicting lifetime depres-
sion and anxiety diagnoses or sensitivity. This stresses the 
importance of replication studies with regard to OXTR 
gene variants in general populations as well as in clearly 
established clinical samples.
Keywords OXTR · Oxytocin · Single nucleotide 
polymorphism · Anxiety · Depression · Childhood 
maltreatment
Introduction
Childhood maltreatment, including physical, sexual and 
emotional abuse, as well as physical and emotional neglect, 
has repeatedly been shown to be a strong risk factor for the 
development of stress-related disorders like depression and 
anxiety [1–3]. However, not all individuals that have expe-
rienced childhood maltreatment develop mental disorders 
in later life, indicating the presence of resilience or vulner-
ability factors that influence the consequences of such neg-
ative life experiences. Genetic and (neuro)biological factors 
that are involved in the processing of stress may play a role 
in the resilience and vulnerability to major life stressors [4]. 
In the current study we focus on the oxytocin system.
Oxytocin is a neuropeptide long known to be involved 
in birth and lactation, and in recent decades its role in 
human social behavior has been studied extensively. It has 
been associated with emotional bonding between parents 
and infants, trust, generosity and empathy, and is found to 
reduce anxiety in stressful situations [5–7]. Individual dif-
ferences exist in basal oxytocin levels, and in oxytocin and 
Abstract 
Background The oxytocin receptor (OXTR) gene may 
be involved in resilience or vulnerability towards stress, 
and hence in the development of stress-related disorders. 
There are indications that OXTR single nucleotide poly-
morphisms (SNPs) interact with early life stressors in pre-
dicting levels of depression and anxiety. To replicate and 
extend these findings, we examined whether three litera-
ture-based OXTR SNPs (rs2254298, rs53576, rs2268498) 
interact with childhood maltreatment in the development of 
clinically diagnosed depression and anxiety disorders.
Methods We included 2567 individuals from the Nether-
lands Study of Depression and Anxiety. This sample con-
sisted of 387 healthy controls, 428 people with a current 
or past depressive disorder, 243 people with a current or 
past anxiety disorder, and 1509 people with both lifetime 
depression and anxiety diagnoses. Childhood maltreatment 
was measured with both an interview and via self-report. 
Additional questionnaires measured depression and anxiety 
sensitivity.
Results Childhood maltreatment was strongly associated 
with both lifetime depression and anxiety diagnoses, as 
well as with depression and anxiety sensitivity. However, 
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oxytocin receptor (OXTR) gene polymorphisms. Human 
brain-imaging studies have shown that variations in OXTR 
gene polymorphisms are related to structural and functional 
variations in the amygdala, hypothalamus and cingulate 
gyrus, which are all involved in the processing of emo-
tions and stress [8]. OXTR gene variations have often been 
linked to autism spectrum disorders [9], but the OXTR 
gene may be involved in the development and/ or mainte-
nance of anxiety and depressive disorders as well.
Genome wide association studies (GWAS), including 
a mega-analysis, have not yielded any direct associations 
between OXTR gene polymorphisms and depressive disor-
ders [10, 11]. One small candidate gene study did report 
evidence for involvement of OXTR gene single nucleotide 
polymorphisms (SNPs) rs2254298 and rs53576 in clinically 
diagnosed major depressive disorder [12]. With regard to 
anxiety disorders (including generalized anxiety disorder, 
panic disorder and phobias), only a few GWAS and candi-
date gene studies have been reported in clinical samples so 
far [13, 14], with no report of any direct associations with 
the OXTR gene. Most evidence so far for involvement of 
the OXTR gene in both anxiety and depression comes from 
candidate gene studies looking at associations between 
OXTR SNPs and (endo-)phenotypes of anxiety and depres-
sion. That is, associations between the OXTR gene and per-
sonality or cognitive emotional characteristics that convey 
vulnerability for stress-related disorders have been found 
(e.g. [15–21]). These findings also suggest a possible com-
mon genetic involvement of the OXTR gene in the vulner-
ability to develop depression and anxiety.
Furthermore, there have been studies examining asso-
ciations between OXTR gene polymorphisms and levels 
of anxiety and depression in community samples [22–25]. 
Interestingly, in all of these studies the OXTR gene poly-
morphisms interacted with stressful life experiences in pre-
dicting levels of anxiety or depression. That is, Thompson 
et  al. [25] showed that OXTR SNP rs2254298 interacted 
with adverse parental environment to predict symptoms of 
depression and anxiety in a sample of 92 Caucasian adoles-
cent girls. More recent findings show that another OXTR 
SNP (rs53576) moderated the association between mater-
nal depression in early childhood and depressive symptoms 
in a sample of 441 adolescents [23]. Similarly, McQuaid 
et al. [24] showed that in a sample of 288 students, early-
life maltreatment was associated with depressive symp-
toms, and that the OXTR SNP rs53576 moderated this 
relationship. Furthermore, Myers et al. [22] found early life 
trauma to interact with OXTR SNPs in predicting levels of 
anxiety, stress and depression in a sample of 653 individu-
als. Hence, the effects of early life stress on depression and 
anxiety may depend on variants of the OXTR gene, indicat-
ing that certain OXTR SNPs confer differential susceptibil-
ity to stressful early life environments.
These prior studies examining OXTR polymorphisms 
in interaction with early life stress have used relatively 
small sample sizes. Replication of these findings hence 
merits consideration, also bearing in mind that replica-
tions of gene–environment interaction effects in other 
genetic domains, like the serotonergic system, have been 
inconsistent [26–28]. Furthermore, none of these studies 
examined clinically diagnosed depression and anxiety dis-
orders. Therefore, our intention is to investigate in a large 
Caucasian sample from the Netherlands Study of Depres-
sion and Anxiety (NESDA), whether OXTR SNPs interact 
with experiences of childhood maltreatment in predicting 
clinically diagnosed lifetime depression and/ or anxiety 
disorders. Based on previous findings in this area, as dis-
cussed above [12, 22–25], the OXTR SNPs rs2254298 
and rs53576 will be examined. In addition, the OXTR 
SNPs rs1042778 and rs2268498, which are thought to be 
involved in social behavior and negative emotionality [8, 
21, 44], will be included as well. To increase the reliability 
of the measurement of childhood maltreatment, both inter-
view-based and self-report measures are included. Also, in 
addition to the clinical diagnoses, measures of depression 
and anxiety sensitivity are used as outcomes measures as 
well to more closely replicate previous findings on vulner-
ability factors for anxiety and depression.
Methods and materials
Sample selection
Participants for our analyses were derived from the Nether-
lands Study of Depression and Anxiety (NESDA). NESDA 
is an ongoing prospective cohort study (N = 2981). For 
this study subjects with current depressive and/or anxiety 
disorders, patients with remitted depressive and/or anxi-
ety disorders, and lifetime healthy controls were recruited 
from specialized mental health care, primary care, and the 
general population. An inclusion criterion was an age of 
18 through 65 years. Excluded were individuals with a pri-
mary diagnosis of psychotic, obsessive compulsive, bipolar, 
or severe addiction disorder, and not being fluent in Dutch. 
For further details on the design, objectives, and protocol 
of NESDA we refer to Penninx et al. [29]. The study pro-
tocol was approved by the Ethical Review Board of the VU 
University Medical Center and by local review boards of 
each participating institute. After full information about the 
study was provided, written informed consent was obtained 
from all participants.
Our selection from the NESDA sample was based on 
the following criteria: (1) participants had to have a current 
or preceding (i.e. lifetime) diagnosis of depressive and/or 
anxiety disorders (n = 2180), or had never been diagnosed 
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with either disorder (n = 387), including data from all pro-
spective NESDA waves, covering 6 years of follow-up; 
(2) genomic data had to be available; and (3) participants 
had to be of North-European descent, which was based on 
reported birth country and nationality, and confirmed with 
ancestry-informative principal components (PC).
Measures
Childhood Maltreatment (CM) was assessed retrospec-
tively during the first NESDA wave, using a semi-struc-
tured childhood trauma interview, previously used in the 
Netherlands Mental Health Survey and Incidence Study 
[1]. In this interview, participants are asked whether they 
have experienced emotional neglect, emotional, physical 
and/or sexual abuse before the age of 16 years. Emotional 
neglect was described as “Nobody ever listened to you at 
home, your problems were ignored, or you had the feeling 
not being able to find any attention or support from your 
parents.” Emotional abuse was described as “You were 
verbally abused, unjustly punished, or your brothers and 
sisters were favored, but no bodily harm was done.” Physi-
cal abuse was defined as “Being kicked, hit with or with-
out an object, or being physically maltreated in any other 
way.” Sexual abuse was defined as “Being touched sexu-
ally by anyone against your will, or being forced to touch 
anyone sexually.” After an affirmative answer, details on 
the frequency of these events and the perpetrators involved 
were asked for. Full data on this semi-structured childhood 
trauma interview was missing for 9 persons. For any type of 
CM, if it happened more than once, it was coded as present. 
The mean number (±SD) of CM types was 0.90 (±1.16), 
with 53.6% (n = 1376) reporting no CM, 18.8% (n = 481) 
reporting one type of CM, 14.9% (n = 382) reporting two 
types of CM, 9.0% (n = 231) reporting three types of CM, 
and 3.4% (n = 88) reporting 4 types of CM. For the main 
statistical analyses, the presence of CM was defined as 0 
versus ≥1 type of CM.
In addition to the childhood trauma interview, partici-
pants also filled in a retrospective self-report questionnaire 
on the experience of CM, the Childhood Trauma Ques-
tionnaire (CTQ) short-form [30, 31] during the fourth 
NESDA wave, 4 years after baseline. The CTQ short form 
is a 28-item questionnaire developed to measure five types 
of childhood maltreatment, i.e., physical, sexual and emo-
tional abuse, as well as physical and emotional neglect. 
Each scale of the CTQ consist of five items (exclud-
ing three minimization items) scored on five-point Likert 
scales. A total CTQ score is calculated by adding the five 
scales, leading to a maximum score of 125. Full data on the 
CTQ was available for 2011 persons.
DSM-IV diagnoses (American Psychiatric Associa-
tion, 2001) of depressive disorders (DEP; major depressive 
disorder or dysthymia) and anxiety disorders (ANX; gen-
eralized anxiety, social phobia, panic with or without ago-
raphobia, or agoraphobia without history of panic) were 
determined by means of the Composite Interview Diagnos-
tic Instrument (CIDI), which was administered by trained 
research staff. The CIDI has high reliability and validity 
[32]. CIDI data from four waves, including 6 years of fol-
low-up and retrospective diagnostic information were used 
to examine lifetime occurrence of depression and/ or anxi-
ety disorder.
To examine more underlying vulnerability to depression 
and anxiety, the revised Leiden Index of Depression Sen-
sitivity (LEIDS-R [33], n = 2267) and the Anxiety Sensi-
tivity Index (ASI [34], n = 2233), acquired during the first 
NESDA wave, were used. The LEIDS-R is a measure of 
cognitive reactivity to sad mood. The questionnaire con-
sists of 34 items with a five-point Likert scale, ranging from 
‘not at all’ (0) to ‘very strongly’ (4). Examples of items are 
“When I feel down, I lose my temper more easily” or “In a 
sad mood I do more things that I will later regret”. The ASI 
measures the degree to which subjects fear anxiety symp-
toms. The questionnaire consists of 16 items with a five-
point Likert scale, ranging from ‘hardly’ (1) to ‘very much’ 
(5). Examples of items are “It scares me when I am unable 
to keep my mind on a ‘task’” or “It scares me when my 
heart beats fast”. For the current study the total scales of 
the LEIDS-R and ASI were examined.
Genotyping and imputation
Data on the four OXTR SNPs of interest were extracted 
from a dataset of a larger GWAS project including sam-
ples from NESDA. Methods for biological sample collec-
tion and DNA extraction [35] and imputation method and 
quality control (QC) checks [36] have been extensively 
described. Briefly, genotyping has been done on multiple 
chip platforms (Affymetrix-Perlegen 5.0 and Affymetrix 
6.0) for several partly overlapping subsets, and QC has 
been performed within, as well as between platforms and 
subsets. Subsequently, data were imputed using the 1000 
Genomes phase 1 INTEGRATED RELEASE version 3 
ALL panel. Post-imputation QC included Minor Allele 
Frequencies (MAF) >0.01, INFO >0.4 and Hardy Wein-
berg Equilibrium (HWE) p > 0.00001. One of the selected 
OXTR SNPSs (rs1042778) did not pass post-imputation 
QC, and was not included in further analyses. The R2 val-
ues for rs2254298, rs53576 and rs2268498 were, respec-
tively, 0.94, 0.76 and 0.77.
Statistical analyses
ANOVAs and Chi square tests were used to determine 
between-group differences in demographic and clinical 
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features. To estimate direct and interaction effects of 
the OXTR SNPs and CM on lifetime depression and/or 
anxiety occurrence, logistic regression analyses were per-
formed with lifetime diagnostic status as dependent vari-
able (0 = control group, 1 = DEP and/ or ANX). Gender 
(0 = male, 1 = female), age and years of education were 
included in each model as covariates, followed by the 
OXTR SNPs in three separate analyses to examine their 
individual direct effects on diagnostic outcome. Due to 
the low frequency of AA homozygotes of SNPs rs53576 
and rs2254298 (see Table 1) the SNP distributions were 
dichotomized for analyses by comparing A-allele carriers 
(AA and AG genotypes, coded as 1) to the GG genotypes 
(coded 0). For rs2268498, the C-allele carriers (CC and 
CT genotypes, coded 1) were compared to the TT gen-
otype (coded 0). This way we tested dominant models 
for previously found risk alleles in all three SNPs. In a 
next analysis CM assessed in the interview (0 = no CM, 
1 = any type of CM) was entered to examine its direct 
effect. Lastly, the interactions between each SNP and 
CM were added to the logistic regression models, includ-
ing the main effects of the concerning SNP and CM. 
To control for population stratification, three ancestry-
informative PCs derived from Dutch GWA data [37] were 
included in the analyses as covariates, but controlling for 
the PCs did not affect any of the results. Associations 
between predictors and diagnostic status are expressed as 
odds ratios (ORs) with 95% confidence intervals (CI).
To examine whether the OXTR SNPs would be differ-
entially associated with either DEP or ANX, we repeated 
these logistic regression analyses by separately comparing 
the groups with DEP (including comorbid DEP + ANX; 
n = 1937) and ANX (including comorbid DEP + ANX; 
n = 1752) to the control group (n = 387). Furthermore, 
two multiple regression analyses were performed with the 
LEIDS-R and ASI total scores as outcome measures. In 
these multiple regression analyses, the three SNPs were 
separately included as predictors, followed by CM and the 
interaction between the concerning SNP and CM. Again 
age, gender, education and the three PCs were analyzed as 
covariates.
In addition, all above analyses were repeated with the 
CTQ total score a measure of CM. The CTQ data were 
log-transformed to reduce non-normality, multiplied by ten 
for interpretation purposes, and centralized to perform the 
interaction analyses. Lastly, possible specific contributions 
of the different types of maltreatment were explored by 
repeating all analyses with the four CM subtypes from the 
interview and the five CM subtypes from the CTQ.
The logistic and multiple regression analyses were per-
formed in SPSS version 23. In addition, Hardy–Weinberg 
equilibrium, MAFs, pairwise LD between SNPs, and hap-
lotype association analysis using case–control samples 
Table 1  Demographic 
characteristics, maltreatment 
history and OXTR genotypes 
for healthy controls and per 
diagnostic group
CM childhood maltreatment, CTQ Childhood Trauma Questionnaire, DEP depressive disorder, ANX anxi-
ety disorder, - no comorbid depressive or anxiety disorder, OXTR oxytocin receptor, SNP single nucleotide 
polymorphism, LEIDS-R revised Leiden Index of Depression Sensitivity, ASI Anxiety Sensitivity Index
Characteristic Control (n = 387) DEP- (n = 428) ANX- (n = 243) DEP + ANX (n = 1509)
% Female 58.7 65.4 62.6 69.1
Age in years (SD) 43.0 (14.3) 42.6 (12.9) 41.9 (14.1) 41.9 (12.5)
Education in years (SD) 13.1 (3.3) 12.5 (3.2) 12.4 (3.2) 11.8 (3.3)
% CM on interview 17.6 38.7 34.3 57.6
CTQ total score (SD) 33.4 (9.7) 39.4 (13.5) 37.2 (11.9) 43.9 (14.9)
LEIDS-R (SD) 15.7 (12.3) 30.1 (17.0) 24.7 (15.2) 42.4 (17.6)
ASI (SD) 23.0 (5.2) 25.5 (7.1) 30.1 (9.5) 32.6 (9.6)
OXTR SNP rs53576
 % AA 12.1 10.0 12.8 12.1
 % AG 46.3 47.9 49.4 45.9
 % GG 41.6 42.1 37.9 41.9
OXTR SNP rs2254298
 % AA 1.0 0.5 0.4 0.4
 % AG 8.0 16.1 9.1 11.1
 % GG 91.0 83.4 90.5 88.5
OXTR SNP rs2268498
 % CC 20.9 18.0 21.8 20.7
 % CT 54.0 53.5 49.8 49.1
 % TT 25.1 28.5 28.4 30.2
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were computed using Haploview 4.2 software. All together 
30 interaction effects (three SNPs times five outcomes 
times two measures of CM) were examined and correc-
tion for multiple comparison is therefore warranted. How-
ever, the five diagnostic outcomes are highly correlated, as 
well the two CM measures, and Bonferroni correction was 
therefore only applied to the three SNPs in the main analy-
ses. Hence, the p value for statistical significance was set at 
0.017 for the main analyses, and for the explorative analy-
ses with the five different CM sub-types at 0.0034.
Results
Sample characteristics
In total 2567 participants (86.1%) were selected from the 
NESDA sample, with a mean age of 42.2 years [standard 
deviation (SD) ± 13.0] and 33.7% (n = 866) males. Table 1 
shows demographic characteristics, CM history (inter-
view and CTQ based) and genotype status per diagnostic 
group. People with a DEP and/ or ANX disorder reported a 
lower number of years of education (ps < 0.02), and higher 
levels of abuse (ps < 0.001 for the interview, ps < 0.05 for 
the CTQ) than the control sample. Within the comorbid 
DEP + ANX group even more than 50% reported any type 
of abuse. The DEP only (DEP-) and DEP + ANX samples 
included more women than the control group (ps < 0.05). 
People who reported any type of CM were more often 
female, older, and attained less years of education than peo-
ple who did not report CM (ps ≤ 0.001), hence gender, age 
and education were included in all analyses as covariates.
All diagnostic groups showed higher LEIDS-R scores 
than controls, and all groups significantly differed from 
each other, with the comorbid group showing the high-
est scores, followed by DEP, ANX and controls (all 
p’s < 0.001). All diagnostic groups also showed higher ASI 
total scores than controls, and all groups significantly dif-
fered from each other, with the comorbid group showing 
the highest scores, followed by ANX, DEP, and controls 
(all p’s < 0.001), see Table 1.
In the current full sample, MAF ≥ 0.05, HWE p > .10 
and Linkage Disequilibrium (LD) between rs2254298 and 
rs53576 was d′ = 0.51, between rs53576 and rs2268498 
was d′ = 0.78 and between rs2254298 and rs2268498 
was d′ = 0.30. Variation on the SNPs was independ-
ent from CM history (interview and CTQ total scores, 
ps > 0.13), age, gender and education (ps > 0.08). With 
regard to the CM subscales (four for the interview and five 
for the CTQ), emotional neglect measured with the inter-
view was associated with the GG genotype of rs53576 
[χ2(1) = 4.18, p = 0.04] and with the TT genotype of 
rs2268498 [χ2(1) = 4.43, p = 0.04], while emotional neglect 
measured with the CTQ was associated with the A-allele 
of rs2254298 [F(1,2010) = 4.27, p = 0.04]. These findings 
could be due to chance as 27 comparisons were made (nine 
scales times three SNPs). However, emotional abuse meas-
ured with the interview was also significantly associated 
with the TT genotype of rs2268498, with a much lower p 
value [χ2(1) = 10.3, p = 0.001], which suggests the possibil-
ity of a gene by environment correlation.
Associations between SNPs, CM and diagnostic status
No significant main effects of the OXTR SNPs, and no sig-
nificant interaction effects between the SNPs and CM were 
found in the prediction of DEP and/or ANX, neither with 
the interview based score nor with the CTQ (see Table 2). 
Results were similar when we repeated these analyses for 
the people with lifetime DEP or ANX versus controls sepa-
rately (see Table 2).
As previously shown, CM was significantly associated 
with higher risk for DEP and/or ANX [interview and CTQ, 
respectively, OR = 4.97; 95% CI (3.76, 6.57), p < 0.001; 
OR = 2.09; 95% CI (1.84, 2.39), p < 0.001], which was sim-
ilar to findings when lifetime DEP or ANX versus controls 
were analyzed separately (both ps < 0.001).
For all three outcome comparisons the CM subtypes 
from the interview and CTQ were analyzed in interaction 
with the three SNPs as well. None of the interactions with 
the CM subtypes reached significance (all ps > 0.04, data 
not shown).
We furthermore examined LD and haplotype associa-
tions in each of the three samples (any diagnosis vs. con-
trols, all DEP vs. controls, and all ANX vs. controls). LD 
was d′=0.78 between rs53576 and rs2268498 in all three 
analyses, but haplotype associations were non-significant.
Associations between SNPs, CM and depression 
and anxiety sensitivity
No significant main effects of the OXTR SNPs, and no sig-
nificant interaction effects between the SNPs and CM were 
found in the prediction of depression sensitivity or in the 
prediction of anxiety sensitivity (see Table 3).
As expected, a history of CM was associated with higher 
scores on the LEIDS-R (interview and CTQ, respectively, 
β = 0.32, p < 0.001, β = 0.36, p < 0.001) and with higher 
scores on the ASI (interview and CTQ, respectively, β = 
0.13, p < 0.001, β = 0.16, p < 0.001).
For both the LEIDS-R and ASI the CM subtypes from 
the interview and CTQ were analyzed in interaction with 
the three SNPs as well. None of the interactions with the 
CM subtypes reached significance (all ps > 0.01, data not 
shown).
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Table 2  The effects of CM 
(interview and CTQ), the 
three OXTR SNPs, and their 
interactions on the presence 
of any diagnosis (ANX and/
or DEP), ANX or DEP versus 
healthy controls
The direct effects of the SNPs, CM and their interaction effects (SNP × CM) on the three outcome compar-
isons were estimated in separate logistic regression models including age, gender, and education as covari-
ates. The models estimating SNP*CM also included the main effects of the concerning SNP and CM
CM childhood maltreatment, CTQ Childhood Trauma Questionnaire, DEP depressive disorder, ANX anxi-
ety disorder, SNP single nucleotide polymorphism
Outcome comparison Direct effect SNP × CM interview SNP × CM-CTQ
OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value
DEP and/or ANX vs control
 CM-interv 4.97 (3.76–6.57) <0.001
 CM-CTQ 2.09 (1.84–2.39) <0.001
 rs53576_A 1.01 (0.81–1.26) 0.92 1.00 (0.57–1.76) 0.99 1.16 (0.89–1.50) 0.28
 rs2254298_A 1.44 (0.99–2.09) 0.06 0.92 (0.37–2.28) 0.85 0.73 (0.49–1.07) 0.11
 rs2268498_C 0.81 (0.63–1.05) 0.10 0.98 (0.52–1.83) 0.95 0.93 (0.69–1.24) 0.60
DEP vs control
 CM interv 5.41 (4.08–7.16) <0.001
 CM-CTQ 2.20 (1.92–2.51) <0.001
 rs53576_A 0.99 (0.79–1.23) 0.90 1.06 (0.60–1.86) 0.84 1.18 (0.91–1.54) 0.22
 rs2254298_A 1.48 (1.01–2.16) 0.04 0.86 (0.34–2.16) 0.75 0.71 (0.48–1.06) 0.09
 rs2268498_C 0.80 (0.62–1.02) 0.08 1.01 (0.54–1.91) 0.97 0.97 (0.72–1.30) 0.81
ANX vs control
 CM interv 5.67 (4.27–7.52) <0.001
 CM-CTQ 2.18 (1.91–2.50) <0.001
 rs53576_A 1.01 (0.81–1.28) 0.86 0.98 (0.55–1.72) 0.93 1.14 (0.87–1.48) 0.35
 rs2254298_A 1.23 (0.87–1.88) 0.21 0.96 (0.38 − 0.243) 0.93 0.74 (0.49–1.10) 0.14
 rs2268498_C 0.80 (0.62–1.03) 0.08 1.00 (0.53–1.90) 0.99 0.93 (0.69–1.26) 0.63
Table 3  The effects of CM 
(interview and CTQ), the 
three OXTR SNPs, and their 
interactions on depression 
sensitivity (LEIDS-R) and 
anxiety sensitivity (ASI)
The direct effects of the SNPs, CM and their interaction effects (SNP*CM) on the two outcomes were 
estimated in separate multiple regression models including age, gender, and education as covariates. The 
models estimating SNP*CM also included the main effects of the concerning SNP and CM
CM Childhood Maltreatment, CTQ Childhood Trauma Questionnaire, SNP single nucleotide polymor-
phism
Outcome Direct effect SNP × CM-interview SNP × CM-CTQ
Beta p value Beta p value Beta p value
LEIDS-R
 CM interview 0.32 <0.001
 CM-CTQ 0.36 <0.001
 rs53576_A 0.39 0.64 0.01 0.71 −0.004 0.91
 rs2254298_A 0.02 0.41 0.02 0.54 0.02 0.30
 rs2268498_C −0.01 0.50 −0.004 0.92 0.05 0.26
ASI
 CM interview 0.13 <0.001
 CM-CTQ 0.16 <0.001
 rs53576_A 0.03 0.11 0.01 0.72 −0.02 0.56
 rs2254298_A 0.01 0.54 0.05 0.12 0.009 0.71
 rs2268498_C −0.009 0.68 0.01 0.77 0.009 0.83
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Discussion
In the current study we replicated the effect that CM by 
itself is a strong predictor of both depression and anxiety 
diagnoses and sensitivity, as has been shown before (e.g. 
[2]). However, no indications were found for moderation 
of these associations by three literature-based OXTR SNPs 
(rs2254298, rs53576 and rs2268498). Previous studies 
reporting interactions between OXTR SNPs and stressful 
early life experiences examined symptom levels of anxiety 
and depression in community samples, or (endo)phenotypic 
characteristics of anxiety and depression [22–25], while in 
the current study we examined a large clinical sample with 
lifetime depression and/ or anxiety disorders. Non-clinical 
or underlying characteristics of depression and anxiety may 
be more suitable to examine in genetic risk studies, as they 
can be defined more precise than the quite broad diagnos-
tic categories of clinical depression and anxiety. However, 
in the current sample we did not find evidence for gene by 
environment interactions on more trait related depression 
and anxiety sensitivity measures either.
Possibly, despite our large clinical sample, this sample 
size was still too small to detect gene by environment inter-
actions. Recently, discussions have been ongoing about the 
validity of many candidate-gene by environment interac-
tion studies in psychiatry [4, 38, 39], and the importance of 
large replication studies with clear disease and environment 
measures in this area is stressed [4]. However, a strength of 
our study was that we used both dichotomous and continu-
ous outcomes to assess depression and anxiety diagnoses 
and sensitivity, testing therefore the gene by environment 
interaction both with a multiplicative (prone to statistical 
artifacts [39]) and additive scale. Also, to increase the reli-
ability of the assessment of childhood maltreatment both 
interview and self-report measures were included.
Besides the negative findings regarding the gene–envi-
ronment interactions, we did not find any main effects of 
the three OXTR SNPs on lifetime clinical depression or 
anxiety either. The null findings regarding associations 
between OXTR SNPs and depression are in line with 
recent GWA studies [10, 11]. Only a small candidate gene 
study by the Costa and colleagues [12] has so far shown 
associations between OXTR SNPs and clinical diagnoses 
of depression. The null findings regarding associations 
between OXTR SNPs and anxiety are also in line with a 
recent GWA study [14]. In contrast, quite a few candidate 
gene studies, often in non-clinical samples, have shown 
main effects of OXTR genes on underlying characteristics 
of depression and anxiety (e.g. [15–21]), which we were 
not able to replicate. While one of the strengths of the cur-
rent study is the clinical assessment of lifetime depression 
and anxiety diagnoses in addition to underlying character-
istics of depression and anxiety, within clinical samples the 
environment may play a very large role in the etiology of 
the disorders. For example, more than half of the people in 
the current comorbid sample (which constituted the larg-
est part of the current clinical sample) reported a history of 
childhood maltreatment. This indicates the need to include 
very large and homogeneous diagnostic groups to disentan-
gle possible genetic contributions to phenotypic outcomes 
[40, 41]. Also, due to the inherently small effects of SNPs 
on such major diagnostic outcomes, a promising route in 
this area might be studies in which polygenic risk scores 
are examined in interaction with environmental influences 
[40].
One unexpected significant finding was the associa-
tion between the reported experience of emotional abuse 
and the TT genotype of SNP rs2268498. This indicates a 
gene–environment correlation, which could have multi-
ple causes, e.g., the genotype could be associated with 
behavior that may evoke abusive behavior by the parents, 
or the genotype could be associated with abusive charac-
teristics and genetic inheritance then leads to associations 
with abuse experiences in the offspring. Some studies have 
shown this SNP to be associated with social and empathic 
behaviors [42–44], and could be of interest to study further 
in the context of maltreatment. Intriguingly, the presence 
of gene–environment correlation may have increased the 
likelihood of detecting spurious gene–environment interac-
tions, none of which were significant in the current study. 
This reinforces the finding of the absence of interplay 
between CM and the OXTR gene variants in depression 
and anxiety.
We did find strong associations between childhood mal-
treatment and both diagnostic measures of depression and 
anxiety as well as depression and anxiety sensitivity meas-
ures. This is a consistent finding in the literature [1–3], 
and indicates the importance of studying factors that are 
involved in both risk and resilience with regard to the psy-
chosocial effects of childhood maltreatment. Knowledge on 
specific genetic markers of vulnerability or susceptibility 
can point to biological mechanisms that could be of interest 
for personalized diagnostic and therapeutic approaches.
Limitations and future directions
While the current sample size is quite large for a candi-
date gene study, the study may still be underpowered for 
investigating gene by environment interactions [4, 38]. 
Thus, the results remain to be replicated, both in Cau-
casian samples and other ethnical groups, as ethnicity is 
also known to influence the role of the OXTR [45]. And 
even though we measured childhood maltreatment quite 
extensively, the measurement of stressful early life expe-
riences could be broadened to other childhood traumas 
and later life trauma, or by using multiple informants 
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in addition to only self-report, so that social desirable 
answering, recall bias and memory problems can be 
reduced. Furthermore, there are other OXTR SNPs that 
were not part of the current investigation (see e.g. [16, 18, 
22]) that may be involved in the development of depres-
sion or anxiety. The current SNPs rs2254298 and rs53576 
are located on one of the introns of the OXTR gene on 
chromosome 3, while rs2268498 is located in the promo-
tor region of the gene. These SNPs are part of haplotype 
blocks that have previously been examined in association 
with depression and anxiety outcomes [18, 22], and are 
most often mentioned in the literature concerning depres-
sion, anxiety and related psychological outcomes [8]. We 
therefore considered these SNPs to be most important to 
examine in the current context, but future studies may opt 
for gene-set analyses or pathway analyses involving the 
oxytocin system.
It may furthermore be the case that the OXTR gene 
does not (only) moderate the effect of early life stress on 
later psychological outcomes, but that certain OXTR gene 
variants are only expressed under stressful circumstances. 
Such gene–environment interactions could be explained 
by epigenetic effects, which encompass processes by 
which environmental factors influence expression of genes 
via epigenetic modifications. Epigenetic modulations of 
the OXTR gene have indeed been shown in rodents and 
humans [46–51]. For example, Unternaehrer et  al. [49] 
showed that low maternal care in human childhood was 
associated with greater OXTR gene methylation. Depres-
sion and anxiety in turn have been associated with higher 
levels of OXTR methylation, and these were moderated by 
the OXTR SNP rs53576 [47, 48, 51]. More methylation 
of the OXTR gene is assumed to result in reduced OXTR 
expression [46]. Hence, epigenetic processes, under the 
influence of the environment, may play a crucial role in the 
expression of the OXTR gene, and through these mecha-
nisms affect behavioral outcomes. Hence, future studies 
could include measurements of epigenetic modulations of 
the OXTR gene, mRNA and OXTR expression, or sensitiv-
ity to oxytocin, as well as more elaborate (endo)phenotypes 
and underlying characteristics of depression and anxiety. 
Interactions with other hormonal systems, including their 
genetic predispositions, should be elucidated as well, as the 
oxytocin system may interact with monoaminergic systems, 
inflammatory processes, and growth factors in developing 
stress-related disorders [52].
Lastly, while in recent years clinical trials have been 
performed to examine the effects of oxytocin administra-
tion on anxiety and depressive disorders [53, 54], the role 
of individual differences in genetic makeup of the oxytocin 
system and the role of early life trauma in both the etiology 
of these disorders, and in the possible moderation of treat-
ment effects are still unclear. Hence, the possible clinical 
application of genetically informed treatments with regard 
to the oxytocin system still remain to be elucidated.
Conclusions
In sum, while the OXTR gene has been found to play a role 
in social processes and underlying characteristics of both 
anxiety and depression, there is little evidence for a role of 
the OXTR in the etiology of clinical expressions of anxiety 
and depression. That is, GWA studies have not implicated 
a role for the OXTR, and only one candidate gene study so 
far has shown associations of depression with OXTR SNPs. 
While studies in non-clinical population suggest the OXTR 
gene may interact with early life stress in the development 
of depressive and anxiety symptomatology, here we show 
that OXTR SNPs are not involved in moderating the effects 
of early life stress on lifetime anxiety and depressive dis-
orders. These findings stress the importance of replication 
research within the domain of oxytocin research, both in 
the general population as well as in clearly established clin-
ical samples.
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